Biophytis S.A. (BPTSY)
USD 3.05
(0.0%)
USD 3.05
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 17.5 Million EUR | -31.36% |
| 2022 | 25.5 Million EUR | -22.85% |
| 2021 | 33.05 Million EUR | 8.32% |
| 2020 | 30.51 Million EUR | 7.89% |
| 2019 | 28.28 Million EUR | 66.55% |
| 2018 | 16.98 Million USD | 197.05% |
| 2017 | 5.71 Million USD | 39.91% |
| 2016 | 4.08 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 19.6 Million EUR | 0.0% |
| 2023 FY | 17.5 Million EUR | -31.36% |
| 2023 Q4 | 17.5 Million EUR | 0.0% |
| 2022 Q2 | 32.33 Million USD | 0.0% |
| 2022 Q4 | 25.5 Million EUR | 0.0% |
| 2021 Q2 | 35.3 Million USD | 0.0% |
| 2021 Q4 | 34.74 Million USD | 0.0% |
| 2020 Q4 | 24.93 Million USD | 0.0% |
| 2020 Q2 | 26.15 Million USD | 0.0% |
| 2019 Q4 | 28.28 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 67.156% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -82.713% |
| SQZ Biotechnologies Company | 50.03 Million USD | 65.012% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 75.842% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 70.333% |
| Mesoblast Limited | 188.44 Million USD | 90.709% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -354.575% |
| Genus plc | 485 Million USD | 96.39% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -199.653% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -595.76% |
| Marizyme, Inc. | 26.67 Million USD | 34.369% |
| ContraFect Corporation | 32.53 Million USD | 46.182% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -360.726% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -783.638% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -357.398% |
| Intellipharmaceutics International Inc. | 12 Million USD | -45.79% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -48.644% |
| MultiCell Technologies, Inc. | 1617.67 USD | -1082172.466% |
| Accustem Sciences Inc. | 1.07 Million USD | -1522.217% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 77.385% |
| EV Biologics, Inc. | 2.11 Million USD | -727.755% |
| Q BioMed Inc. | 8.13 Million USD | -115.268% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 78.89% |
| Neon Bloom, Inc. | 1.22 Million USD | -1327.778% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -240.215% |
| Biomind Labs Inc. | 1.49 Million USD | -1068.254% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | 92.827% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | 4.868% |
| Skye Bioscience, Inc. | 14.07 Million USD | -24.412% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -770.968% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -12221.051% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -84.954% |
| IMV Inc. | 37.93 Million USD | 53.846% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -8605.223% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -204.701% |
| GB Sciences, Inc. | 5.41 Million USD | -223.164% |
| Alpha Cognition Inc. | 7.16 Million USD | -144.357% |
| HST Global, Inc. | 593.59 Thousand USD | -2849.428% |
| CSL Limited | 18.62 Billion USD | 99.906% |
| Halberd Corporation | 728.71 Thousand USD | -2302.517% |
| Enzolytics Inc. | 365.26 Million USD | 95.207% |
| Resverlogix Corp. | 67.39 Million USD | 74.023% |
| Affymax, Inc. | 8.87 Million USD | -97.358% |
| SYBLEU INC | 681.41 Thousand USD | -2469.308% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -1987.389% |
| argenx SE | 444.95 Million USD | 96.065% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 76.632% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -921.447% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -47.084% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -377.676% |
| AVAX Technologies, Inc. | 3.99 Million USD | -338.375% |
| Zenith Capital Corp. | 27.56 Thousand USD | -63404.65% |
| Genscript Biotech Corporation | 1.32 Billion USD | 98.68% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -7235.975% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -368.831% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -2471.493% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 85.253% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -93.621% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -26058.462% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -1121.011% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 65.169% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -545.646% |
| BioStem Technologies, Inc. | 15.9 Million USD | -10.078% |
| ONE Bio Corp. | 27.49 Million USD | 36.326% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -3667.513% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -63719.477% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -1290.382% |
| Agentix Corp. | 2.51 Million USD | -597.36% |
| LadRx Corporation | 2.2 Million USD | -695.609% |
| Cell Source, Inc. | 15.8 Million USD | -10.761% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -39070.389% |
| Regen BioPharma, Inc. | 5.45 Million USD | -220.792% |
| Regen BioPharma, Inc. | 5.45 Million USD | -220.792% |
| NovAccess Global Inc. | 7.86 Million USD | -122.722% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | 29.251% |
| Itoco Inc. | 1.65 Million USD | -959.044% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -753.378% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -189.43% |
| Kadimastem Ltd | 3.5 Million USD | -399.522% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -4052.971% |
| CytoDyn Inc. | 127.89 Million USD | 86.311% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -41785.205% |
| Mobile Lads Corp. | 1.31 Million USD | -1232.9% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -1017.713% |
| Qrons Inc. | 1.48 Million USD | -1076.022% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -58.507% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -2064.655% |
| Rebus Holdings, Inc. | 5.24 Million USD | -233.987% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -186.92% |
| International Stem Cell Corporation | 5.27 Million USD | -231.772% |
| Bioxytran, Inc. | 3.24 Million USD | -438.778% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -2697.594% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -279.188% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 57.294% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | 21.367% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -764.407% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -219.598% |
| Neutra Corp. | 973.52 Thousand USD | -1698.364% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | 39.66% |
| PureTech Health plc | 125.58 Million USD | 86.059% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -365.984% |
| IXICO plc | 1.9 Million USD | -821.311% |
| IntelGenx Technologies Corp. | 20.52 Million USD | 14.718% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 83.056% |
| CSL Limited | 18.62 Billion USD | 99.906% |
| Cellectis S.A. | 249.36 Million USD | 92.979% |